Efgartigimod alfa

efgartigimod alfa · argenx SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Efgartigimod alfa, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa